0001415889-21-001454.txt : 20210311
0001415889-21-001454.hdr.sgml : 20210311
20210311192317
ACCESSION NUMBER: 0001415889-21-001454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210309
FILED AS OF DATE: 20210311
DATE AS OF CHANGE: 20210311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cozzens Todd C
CENTRAL INDEX KEY: 0001382487
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 21734919
MAIL ADDRESS:
STREET 1: ONE FEDERAL STREET
STREET 2: 25TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-03112021_040305.xml
X0306
4
2021-03-09
0001604821
Natera, Inc.
NTRA
0001382487
Cozzens Todd C
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
false
false
false
Common Stock
2021-03-09
4
M
0
29475
1.3855
A
36753
D
Common Stock
2021-03-09
4
S
0
29475
100.352
D
7278
D
Common Stock
2021-03-11
4
M
0
20000
1.3855
A
27278
D
Common Stock
2021-03-11
4
S
0
9283
103.378
D
17995
D
Common Stock
2021-03-11
4
S
0
10717
103.967
D
7278
D
Stock Option (right to buy)
1.3855
2021-03-09
4
M
0
29475
0
D
2023-04-17
Common Stock
29475
51383
D
Stock Option (right to buy)
1.3855
2021-03-04
4
M
0
20000
0
D
2023-04-17
Common Stock
20000
31383
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.70 to $103.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.71 to $104.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests in 48 equal monthly installments beginning on April 21, 2013.
/s/ Tami Chen, Attorney-in-Fact
2021-03-11